MARKET

LYRA

LYRA

Lyra Therapeutics, Inc.
NASDAQ
1.470
-0.050
-3.29%
After Hours: 1.500 +0.03 +2.04% 17:56 02/10 EST
OPEN
1.540
PREV CLOSE
1.520
HIGH
1.576
LOW
1.470
VOLUME
24.28K
TURNOVER
--
52 WEEK HIGH
37.50
52 WEEK LOW
1.470
MARKET CAP
2.61M
P/E (TTM)
-0.0618
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LYRA last week (0202-0206)?
Weekly Report · 1d ago
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell
TipRanks · 4d ago
Lyra Therapeutics common stock to be delisted by Nasdaq
TipRanks · 4d ago
Lyra Therapeutics Receives Nasdaq Delisting Notification
Benzinga · 4d ago
Nasdaq Moves to Delist Lyra Therapeutics Over Public Shell Status and Equity Shortfall
Reuters · 4d ago
Weekly Report: what happened at LYRA last week (0126-0130)?
Weekly Report · 02/02 10:34
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 01/28 21:05
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 01/28 17:05
More
About LYRA
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). The Company is developing therapies for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210, the Company’s lead product, is a bioabsorbable nasal implant designed to be administered in a simple, in-office procedure and is intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. LYR-210, being evaluated in the ENLIGHTEN Phase III clinical program, is intended for patients with and without nasal polyps. The drug embedded within LYR-210 is mometasone furoate (MF).

Webull offers Lyra Therapeutics Inc stock information, including NASDAQ: LYRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LYRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LYRA stock methods without spending real money on the virtual paper trading platform.